Vermillion & White Wealth Management Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-282
Closed -$22.4K 174
2025
Q4
$22.4K Buy
282
+1
+0.4% +$79 0.01% 243
2025
Q3
$21.2K Buy
281
+2
+0.7% +$137 0.01% 254
2025
Q2
$19.2K Buy
279
+2
+0.7% +$131 0.01% 238
2025
Q1
$18.8K Sell
277
-65
-19% -$3.89K 0.01% 197
2024
Q4
$15.4K Buy
342
+2
+0.6% +$112 0.01% 209
2024
Q3
$21.4K Sell
340
-298
-47% -$17.4K 0.02% 176
2024
Q2
$37.7K Buy
638
+2
+0.3% +$125 0.03% 151
2024
Q1
$50.8K Buy
636
+1
+0.2% +$76 0.04% 120
2023
Q4
$50.1K Buy
+635
New +$45.2K 0.05% 90

Other funds holding CVS

Vermillion & White Wealth Management Group's CVS Position: Q1 2026 in Review

Vermillion & White Wealth Management Group sold out of CVS Health (CVS) in Q1 2026, closing a stake of 282 shares — an estimated $22.4K sold.

Vermillion & White Wealth Management Group first reported a position in CVS in Q4 2023 and held it in 9 quarters. The position peaked at $50.8K in Q1 2024. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Vermillion & White Wealth Management Group reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
  • Vermillion & White Wealth Management Group sold 282 CVS Health shares in Q1 2026, an estimated $22.4K.
  • Vermillion & White Wealth Management Group first reported a position in CVS Health in Q4 2023 and held it in 9 quarters.
  • Vermillion & White Wealth Management Group's CVS Health position peaked at $50.8K in Q1 2024.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Vermillion & White Wealth Management Group's 13F filing for Q1 2026, filed 14 May 2026.